Cachexia (pronounced kuh-KEK-see-uh) is a complex, multifactorial wasting syndrome defined by an ongoing loss of skeletal muscle mass — with or without loss of fat mass — driven by systemic inflammation from an underlying chronic or critical illness, that cannot be fully reversed by conventional nutritional support alone. The 2011 international expert consensus definition (Fearon et al.) added the qualifier “leads to progressive functional impairment,” distinguishing true cachexia from simple malnutrition or starvation, where nutrition can reverse the wasting. The syndrome is staged as pre-cachexia (early metabolic changes, <5% weight loss), cachexia (≥5% weight loss over 12 months, or BMI <20 with >2% loss, combined with fatigue, anorexia, or low muscle strength), and refractory cachexia (advanced disease, no response to treatment, actively dying). The five most common disease drivers are cancer (cancer cachexia — occurs in up to 80% of advanced malignancies), congestive heart failure (cardiac cachexia), COPD, chronic kidney disease, and HIV/AIDS. The underlying mechanism involves a cytokine storm of TNF-α, IL-1, IL-6, and IFN-γ that drives proteolysis (UPS — ubiquitin-proteasome system), suppresses anabolic signaling (IGF-1, testosterone), elevates REE, and induces anorexia via hypothalamic activation. ICD-10-CM underwent a significant update with the addition of E88.A (disease-associated cachexia) in FY2024, creating a more clinically precise alternative to the nonspecific R64 for cachexia directly attributable to an identifiable underlying condition.
“Condition,” “state of being,” “bodily habit” — from “to have, to hold”; referring to one’s overall physical state/constitution
The composite kakhexía (κακεξία) was used by Hippocrates (~400 BC) to describe the deteriorating physical state of terminally ill patients — making it one of the oldest surviving medical terms still in active clinical use, with over 2,400 years of continuous usage. It entered Latin as cachexia and Middle French as cachexie, arriving in English by the late 16th century (ca. 1541). The prefix kak- (bad) also appears in cacophony (“bad sound”), cacodyl (“bad smell”), and cacosmia. The root hexis (“bodily state/habit”) is related to the Aristotelian philosophical term hexis — a stable disposition or habit of character — applied here to mean the stable physical state of the body. Compare euhexia (good condition) — the etymological antonym, though no longer in clinical use.
🔀 ALIASES / ALTERNATE TERMS
Cachectic(adjective form — “the patient appeared cachectic”; “cachectic habitus”)
Wasting syndrome(lay/clinical synonym; particularly used for HIV-associated wasting — B22.2)
Disease-associated cachexia(ICD-10-CM E88.A — FY2024 addition; when cachexia is directly attributed to an underlying chronic illness)
Cancer cachexia(most studied form; present in up to 80% of advanced cancers; leads to ~20% of cancer deaths directly)
Cardiac cachexia(cachexia in CHF — I50.x + E88.A or R64; strongly associated with mortality in heart failure)
Refractory cachexia(terminal/end-stage cachexia; not responsive to any intervention; coded with underlying condition)
Pre-cachexia(early stage with metabolic changes but <5% weight loss; not separately coded; map to R63.4 or underlying condition)
HIV wasting syndrome(B22.2 — AIDS-defining condition; listed separately in ICD-10-CM Chapter 1)
Anorexia-cachexia syndrome(combined term used in oncology/palliative medicine; anorexia + muscle wasting + metabolic dysregulation)
🔗 RELATED TERMS
Malnutrition — nutritional deficiency that CAN be reversed by adequate intake; distinct from cachexia (cannot be fully reversed nutritionally); E40-E46
sarcopenia — age-related muscle loss WITHOUT inflammatory cytokine driver; sarcopenia M62.84; frequently overlaps with cachexia in elderly
Emaciation — extreme thinness from absence of fat and muscle; R63.4 (abnormal weight loss) or underlying cause; clinical descriptor more than diagnosis
Marasmus — severe caloric malnutrition (non-inflammatory); E41; Excludes1 from R64
Anorexia — loss of appetite; R63.0; a cardinal symptom accompanying cachexia but NOT synonymous with it
TNF-α (Tumor Necrosis Factor-alpha) — primary catabolic cytokine driving cachexia; historically called cachectin because of its role
Proteolysis / Ubiquitin-Proteasome System (UPS) — the cellular mechanism by which cytokines drive muscle protein breakdown in cachexia
CRP (C-Reactive Protein) — acute phase reactant elevated in cachectic states; useful to distinguish inflammatory from non-inflammatory wasting
Albumin / Prealbumin (Transthyretin) — historically used as malnutrition markers; NOTE: per ASPEN/Academy 2012 consensus, low albumin/prealbumin reflects inflammation, NOT nutritional status — do NOT use to diagnose malnutrition or cachexia
Megestrol acetate / Corticosteroids / Mirtazapine — palliative appetite stimulants used in cancer cachexia management
Parenteral nutrition (TPN) — may provide caloric support but does NOT reverse the underlying cytokine-driven catabolism of true cachexia
Cachexia — Excludes1: E41 (nutritional marasmus), E88.A (cachexia due to underlying condition), R63.4 (abnormal weight loss); use when cachexia is not attributable to a specified underlying condition
Disease-associated cachexia (FY2024 addition — use when cachexia is directly attributable to cancer, CHF, CKD, COPD, HIV, or other documented chronic condition; more specific than R64)
Advance care planning; first 30 min (palliative discussions in refractory cachexia — common in late-stage cancer admissions)
⚠️ Coding Note:R64 vs. E88.A is the single most important cachexia coding distinction introduced in recent years. Effective FY2024, E88.A (disease-associated cachexia) should be used — in place of R64 — whenever cachexia is documented as being due to or associated with a specific underlying illness (cancer, CHF, CKD, COPD, HIV, etc.), which covers the vast majority of clinical cachexia cases. R64 is now functionally reserved for cachexia with no identifiable underlying condition — a rare scenario. The Excludes1 note at R64 explicitly excludes E88.A, meaning you cannot code both simultaneously. Always sequence the underlying disease first (e.g., C18.9 for colon cancer, I50.22 for systolic CHF), then E88.A as an additional secondary code. On inpatient profee, cachexia is one of the most underqueried high-yield secondary codes — provider documentation of “wasting,” “cachectic appearance,” “disease-related wasting,” or “cancer-related weight/muscle loss” without explicitly using the word “cachexia” is a CDI query opportunity. Per ASPEN/Academy 2012 consensus, low albumin and prealbumin are NOT diagnostic of malnutrition or cachexia — they reflect systemic inflammation (acute phase reactants); educate your providers accordingly, as using albumin-based language to document malnutrition is increasingly non-compliant with payer audit standards. B22.2 (HIV wasting syndrome) is in Chapter 1 (Infectious diseases) and maps directly — never code B22.2 alongside R64 or E88.A for the same episode of HIV wasting.
Crystal's MCW Coder Hub